Porter Derrell has filed 8 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 12800 shares of Acumen Pharmaceuticals, Inc. ($ABOS) on June 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Porter Derrell | Director | A | Common Stock | 12800 | $0.00 | 12,800.0000 | 60,573,425 | 9999.99% | 0.02% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Porter Derrell | Director | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 60,573,425 | 9999.99% | 0.03% |
| May 28, 2025 | Passage BIO, Inc. | $PASG | Porter Derrell | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| June 10, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Porter Derrell | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 21, 2024 | Passage BIO, Inc. | $PASG | Porter Derrell | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| June 6, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Porter Derrell | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 25, 2023 | Passage BIO, Inc. | $PASG | Porter Derrell | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |
| Jan. 4, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Porter Derrell | Director | A | Stock Option Grant (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |